Lynx1 Capital Management LP - Insider Non-Derivative Transactions at Passage BIO, Inc. (PASG) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jul 24, 2025, Lynx1 Capital Management LP's relationship to Passage BIO, Inc. (PASG) is TenPercentOwner, and currently has 475,971 shares of Common stock, $0.0001 par value per share ("Common Stock"), 591,696 shares of Common Stock, and 9,256,953 shares of Common stock, $0.0001 par value per share.

The charts below show the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PASG insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Lynx1 Capital Management LP - Insider Non-Derivative Transactions of PASG Common stock, $0.0001 par value per share ("Common Stock")

Lynx1 Capital Management LP - Insider Non-Derivative Transactions of PASG Common Stock

Lynx1 Capital Management LP - Insider Non-Derivative Transactions of PASG Common stock, $0.0001 par value per share

Lynx1 Capital Management LP - Insider Non-Derivative Transactions at PASG

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jul 25, 2025	P -- (Common Stock)	66423	5.71	591696
Jul 24, 2025	P -- (Common Stock)	49302	5.74	525273
Jul 23, 2025	P -- (Common stock, $0.0001 par value per share ("Common Stock"))	13123	5.44	475971
Dec 28, 2024	P -- (Common stock, $0.0001 par value per share)	373645	0.65	9256953
Nov 28, 2024	P -- (Common Stock)	29300	0.67	8883308
Nov 27, 2024	P -- (Common Stock)	167055	0.71	8854008
Nov 26, 2024	P -- (Common stock, $0.0001 par value per share ("Common Stock"))	259998	0.56	8686953